- Display 15 Products per page
Published: June 1, 2012 | Price: $495.00 – $990.00
In February and March of 2012, Kalorama Information conducted a survey of 2,000 adults to ask them whether or not they would take a genetic test. This report, Consumer Testing and the Future of DTC Genetic Testing provides those results and compiles surveys from public and private sources to provide the following insights: Have Consumers Used a Self-Test Product? Would They Take a Genetic Test? Are They Concerned About Their Healthcare? What Diseases Are They Most Concerned About?...Published: July 21, 2020 | Price: $7,500.00 $4,000.00
Published: April 19, 2022 | Price: $3,750.00 – $7,500.00
This report, COVID-19 Testing Market Update, 2022, provides market sizing and estimates for COVID-19 tests with some discussion of market impacts of COVID-19. The scourge of COVID-19 continued to occupy laboratories and the in vitro diagnostic (IVD) companies that serve them throughout 2021 and into 2022. Testing already present in large labs and clinics entered the home last year, which added to market revenues. There was 33 BN of revenues in 2021, and the report details the share of antigen,...Published: April 24, 2023 | Price: $5,000.00 – $10,000.00
Covid-19 testing has been at the forefront in battling the pandemic. However, as the pandemic recedes and becomes more endemic, what will happen to the ever-changing COVID-19 testing market? Kalorama Information answers this question and more in COVID-19 Testing Markets, 2023. The pandemic has been a learning curve for all parties to invest in diagnostic systems, as COVID-19 aptly pointed out. Notably, the pandemic reinforced the importance of testing and a significant number of companies are increasing their development of...Published: February 16, 2021 | Price: $3,000.00 – $6,000.00
As the unfortunate milestone of one full year of the global COVID-19 pandemic worldwide is reached, the diagnostic industry has been changed, perhaps permanently. Hundreds of test products are on the market to detect the virus, both for its presence and immune response. And billions of dollars have been added to the in vitro diagnostic market. Companies have doubled and tripled revenues, bought new companies, increased manufacturing, shifted focus to infectious diseases and launched new products. "A 38 Billion Dollar Market...Published: November 2, 2020 | Price: $4,000.00 – $8,000.00
COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: COVID-19 has seen the molecular in...Published: December 1, 2014 | Price: $995.00 – $1,990.00
CT Systems: World Market Analysis Computed Tomography or CT systems has revolutionized imaging and diagnosis. CT scanners continously improve to allow for enhanced resolution, patient comfort and safety. Computed Tomography or CT systems blends software and-rays to obtain crossed images of the body. CT allows physicians to look at a patient from the inside. This study, Computed Tomography (CT) Systems: World Market Analysis features the following market information: Market Size Estimate Geographic Market Breakout (US, BRIC, Europe, Japan) Market Projection...Published: October 31, 2019 | Price: $3,000.00 – $6,000.00
This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture. The topics discussed are the following: The Worldwide IVD Market, 2019-2024 Market Developments in Selected Markets – North America, EU15/Western Europe, Eastern Europe, Japan and China Genetic Testing New POC Innovations Cancer Testing and Personalized Medicine Hematology Glucose Monitoring Advancements HbA1c Testing New Developments in Infectious Diseases Cytology - Increasing Molecular Dx Options...Published: July 1, 2007 | Price: $995.00 – $3,990.00
In light of laboratory pressures to do more with less, laboratory managers transfer cost control onto vendors by means of a constant push for price reductions. In this commercial climate, efficient management of customer and technical service extras is critical. Expertise in managing service offerings will help companies offer service programs that are just enough to differentiate them from the competition. Service programs that offer too much may result in revenue loss. Programs that are perceived to be inadequate place...Published: April 1, 2011 | Price: $150.00 – $300.00
Even though slightly more than half of the US population is female, medical research historically has neglected the health needs of women, other than reproductive issues. However, during the past two decades, there have been major changes in government and private support of women’s health research -- in policies, regulations, and the organization of research efforts. In a recent Institute of Medicine (IOM) report, the Washington DC-based institute found that women’s health research has contributed to significant progress over the...Published: October 30, 2014 | Price: $995.00 – $1,990.00
Diagnostic Markets for Women's Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing) Kalorama Information’s report on Women's Health Diagnostic Markets takes a solid look at the current and developing world markets for key diagnostic tests aimed at the health of women. The report presents market developments in women's health diagnostics, including in-depth analysis of the following testing fields: Ovarian Cancer Testing Urinary Tract Infections Neonatal Jaundice Autoimmune Disease Cystic Fibrosis...Published: August 1, 2008 | Price: $1,500.00 – $7,000.00
Test services, once the norm in the diagnostics industry, then abandoned for reagent sales, are now making a comeback. IVD companies have established cGMP and CLIA-registered labs by which they offer their proprietary tests to physicians, hospitals and reference labs. These tests are outside the oversight of the traditional FDA and CE Mark test commercialization avenue in the U.S, and Europe and so are thought to come to market by what may seem to be the back door. Kalorama has...Published: October 1, 2003 | Price: $1,496.00 – $2,992.00
Diagnostic testing for prion diseases has become more important as countries increase the number of tests to battle the potential public health problem. Academic, government, and industry organizations continue to develop diagnostic testing technologies and policies as preventative measures. The number of prion diagnostic technologies being used and developed for prion diseases primarily reflects the scientific and technical challenges of detecting prion proteins. Growth of prion testing will depend on these technology breakthroughs and the future prevalence of prion disease....Published: December 1, 2003 | Price: $1,496.00 – $2,992.00
Severe Acute Respiratory Syndrome (SARS), which was a new and unidentified disease when it first affected people, ripped through Asia and Toronto from late 2002 into the summer of 2003, before being contained for the season. Taiwan with just 346 reported cases performed 10,000 diagnostic tests. Three years after West Nile Virus (WNV) first appeared in the United States in 1999 with just 62 cases and 7 deaths, the U.S. Center for Disease Control reports thousands of cases and 150...Published: April 1, 2004 | Price: $1,995.00 – $3,990.00
The recent terrorism events, in addition to the ease of travel that allows infectious diseases to spread, and technology developments drive the renewed interest in clinical and environmental infectious disease diagnostics. The combined public health and bio-terrorism markets of several bacterial and protozoan diseases are estimated to be nearly $100 million. This report, the final volume of the Diagnostics for Emerging Infectious Disease Threats series, focuses on diagnostic testing for 11 bacterial and protozoal diseases in clinical and environmental testing:...